FDA Withdraws Approval of Five New Drug Applications from Novartis Pharmaceuticals Corporation and Other Applicants

Summary

Novartis Pharmaceuticals Corporation, along with other applicants, has had the FDA withdraw approval of five new drug applications as the drug products are no longer being marketed, following written notification to the Agency.